Safety and Tolerability of N6LS Administered Intravenously or Subcutaneously: Promising Results From Part 1 of the EMBRACE Study

Conference Reports for NATAP

20th European AIDS Conference
October 15th-18th, 2025
Paris, France


Safety and Tolerability of N6LS Administered Intravenously or Subcutaneously: Promising Results From Part 1 of the EMBRACE Study

	20th European AIDS Conference; October 15-18, 2025; Paris, France